Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
|
|
![](https://www.worldpharmatoday.com/images/article/Weekly_newsletter/comman_images/6.png) |
Industry Insights |
|
|
Forecast: Bioinformatics Industry Will Reach $31.71B By 2031
It is projected that the market for bioinformatics is most likely to expand at a CAGR of 13.4% starting in 2024 and thereby reaching $31.71 billion by 2031.
|
|
![](https://www.worldpharmatoday.com/wp-content/uploads/2018/03/images_article_reports_txcell_financial_results.jpg)
|
|
|
|
|
|
|
|
N4 Pharma's CEO Nigel Theobald Discusses Strategic Moves and Future Outlook in Pharma
In an interview with Nigel Theobald, CEO of N4 Pharma, several key points emerged regarding the company's recent strategic moves and its outlook in the pharmaceutical landscape.
|
|
|
|
|
|
The Future of Healthcare: Interoperability and the Patient Experience
Fragmentation in healthcare data is a stark reality today. Many patients' medical records lie dispersed among several filing cabinets, each originating from a separate physician's office, hospital, or laboratory.
|
|
![](https://www.worldpharmatoday.com/wp-content/uploads/2019/09/patient-in-hospital.jpg)
|
|
|
|
|
|
|
|
The Future of Aesthetic Pharmacology Promising Trends and Innovations
For the past few years, drug development and the aesthetic medicine sphere have experienced significant growth, which is definitely a beneficial thing for pharmaceutical companies all around the world.
|
|
|
|
|
|
BIO Asia–Taiwan 2024 opens July 24th
Global biotech opportunities viewed with an Asian touch Conference Expands into Three Tracks: Innovation & Technology, Investment, and Regional Cooperation Participation from 50 countries.
|
|
![](https://www.worldpharmatoday.com/wp-content/uploads/2019/09/BIo-Asia.jpg)
|
|
|
|
|
|